The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022

Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern inc...

Full description

Bibliographic Details
Main Authors: Saranya Sridhar, Roman M. Chicz, William Warren, Jim Tartaglia, Stephen Savarino, Sanjay Gurunathan, Jean-Francois Toussaint
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-022-33549-6
_version_ 1828108284548087808
author Saranya Sridhar
Roman M. Chicz
William Warren
Jim Tartaglia
Stephen Savarino
Sanjay Gurunathan
Jean-Francois Toussaint
author_facet Saranya Sridhar
Roman M. Chicz
William Warren
Jim Tartaglia
Stephen Savarino
Sanjay Gurunathan
Jean-Francois Toussaint
author_sort Saranya Sridhar
collection DOAJ
description Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern including the most prevalent variant for the coming season. We here discuss recent preclinical and clinical data on COVID vaccine antigens that are potential candidates for an updated vaccine.
first_indexed 2024-04-11T10:44:16Z
format Article
id doaj.art-613c37b00e15421f9f434ba2b8494c53
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-11T10:44:16Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-613c37b00e15421f9f434ba2b8494c532022-12-22T04:29:06ZengNature PortfolioNature Communications2041-17232022-10-011311310.1038/s41467-022-33549-6The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022Saranya Sridhar0Roman M. Chicz1William Warren2Jim Tartaglia3Stephen Savarino4Sanjay Gurunathan5Jean-Francois Toussaint6SanofiSanofiSanofiSanofiSanofiSanofiSanofiCurrently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern including the most prevalent variant for the coming season. We here discuss recent preclinical and clinical data on COVID vaccine antigens that are potential candidates for an updated vaccine.https://doi.org/10.1038/s41467-022-33549-6
spellingShingle Saranya Sridhar
Roman M. Chicz
William Warren
Jim Tartaglia
Stephen Savarino
Sanjay Gurunathan
Jean-Francois Toussaint
The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
Nature Communications
title The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
title_full The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
title_fullStr The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
title_full_unstemmed The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
title_short The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
title_sort potential of beta variant containing covid booster vaccines for chasing omicron in 2022
url https://doi.org/10.1038/s41467-022-33549-6
work_keys_str_mv AT saranyasridhar thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT romanmchicz thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT williamwarren thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT jimtartaglia thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT stephensavarino thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT sanjaygurunathan thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT jeanfrancoistoussaint thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT saranyasridhar potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT romanmchicz potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT williamwarren potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT jimtartaglia potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT stephensavarino potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT sanjaygurunathan potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022
AT jeanfrancoistoussaint potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022